David Moatazedi sold $1.3M of Evolus (EOLS)

Executed Jun 13 2025, disclosed Jun 16 2025, 3 days later.

Value, as filed

$1.3M

127,905 sh across 2 lots

Executed

Jun 13 2025

the trade date, as filed

Disclosed

Jun 16 2025

3 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

David Moatazedi See Remarks profile →

David Moatazedi (See Remarks) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Evolus, Inc. (EOLS). The largest single filing was $950K of EOLS (105,108 sh × $9.04, as filed), executed Sep 2.

The name

EOLS

Evolus, Inc. EOLS · Healthcare · 12 filings in 24 months ticker →

Healthcare · Evolus, Inc., a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Au…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by David Moatazedi in EOLS

EOLSSALE Evolus, Inc. $950K
105,108 sh × $9.04
Exec Sep 2
Filed Sep 4 · 7:04 PM ET EOLSSALE Evolus, Inc. $571K
116,720 sh × $4.89
Exec Mar 17
Filed Mar 18 · 5:30 PM ET EOLSSALE Evolus, Inc. $156K
15,787 sh × $9.87
Exec May 12 2025
Filed May 14 2025 · 5:30 PM ET EOLSSALE Evolus, Inc. $1.4M
103,376 sh × $13.26
Exec Mar 18 2025
Filed Mar 20 2025 · 5:30 PM ET EOLSSALE Evolus, Inc. $114K
10,502 sh × $10.85
Exec Dec 23 2024
Filed Dec 26 2024 · 5:30 PM ET